Skip to content

Comparison of Analgesic Efficacy of Quadratus Lumborum Type 3 and Suprainguinal Fascia Iliaca Compartment Block in Total Hip Arthroplasty Surgery

Comparison of Analgesic Efficacy of Quadratus Lumborum Type 3 and Suprainguinal Fascia Iliaca Compartment Block in Total Hip Arthroplasty Surgery: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06838156
Enrollment
60
Registered
2025-02-20
Start date
2023-02-15
Completion date
2023-08-01
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Consumption, Pain Postoperative

Brief summary

Total Hip Arthroplasty (THA) is a complex surgical procedure frequently performed to treat degenerative conditions in the hip joint. As people's life expectancy increases, the need for hip arthroplasty increases. İnvestigetors aimed to compare the analgesic properties of SIFI and QLB blocks.

Interventions

DRUGBupivacain

Suprainguinal Fascia Iliaca Compartment block was performed with a linear probe placed over the inguinal ligament using a portable ultrasound device. After visualization of the femoral nerve, 30 ml of 0.25% bupivacaine was injected into the fascia iliaca overlying the iliopsoas muscle using an appropriate needle.

Sponsors

Başakşehir Çam & Sakura City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Elective patients scheduled for hip arthroplasty surgery 2. Patient willingness to participate in the study 3. Patients over 18 years age of, ASA I-II-III,

Exclusion criteria

1. Patients not wanting to participate in the study 2. Patients who do not want regional anesthesia technique 3. Allergic or coagulated patients 4. Patients with liver, kidney, lung, heart failure and septic patients 5. Neurological disorder, history of convulsions 6. ASA IV patients

Design outcomes

Primary

MeasureTime frameDescription
Effect on pain scoreAt 1,2,4, 6, 12 and 24 hours after surgeryPostoperative 24-hour Visual Analog Scale was measured. ( 0=best 10=worst)

Secondary

MeasureTime frameDescription
Opioid ConsumptionAt 1,2,4, 6, 12 and 24 hours after surgeryIntravenous patient-controlled analgesia (PCA) with tramadol was administered to both groups in the postoperative period.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026